[CONSOLIDATION_METHOD_TITLE] [CONSOLIDATION_METHOD]
Related Companies
[]
Related Funds
[]
English
oda_MaterialEventDisclosureGeneralAbstract|
Material Event Disclosure General
oda_UpdateAnnouncementFlag|
Update Notification Flag
Hayır (No)
oda_CorrectionAnnouncementFlag|
Correction Notification Flag
Hayır (No)
oda_DateOfThePreviousNotificationAboutTheSameSubject|
Date Of The Previous Notification About The Same Subject
-
oda_DelayedAnnouncementFlag|
Postponed Notification Flag
Hayır (No)
oda_AnnouncementContentSection|
Announcement Content
oda_ExplanationSection|
Explanations
oda_ExplanationTextBlock|

-Unofficial Translation-

Towards the target of being global player of the pharmaceutical industry, GEN continue to its activities to develop activities abroad.

In line with this goal, audit made by Germany Health Authority in GEN manufacturing facility and existing EU GMP (European Union Good Manufacturing Practices) certificate was updated for sterile production area.

Accordingly, in addition to previous marketting authorization approvals marketting authorization approvals was made for new products in European Union (EU) countries.

With the subjected certificate our Company's export potential to EU countries increased and positive impact on our Company's export activities is expected.